Literature DB >> 24755282

Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

Yan Li1, Haijun Zhang1, Hongmei Zhang1, Alyssa K Kosturakis1, Abdul Basit Jawad2, Patrick M Dougherty3.   

Abstract

UNLABELLED: This paper tests the contribution of the toll-like receptors, TLR4 in particular, in the initiation and maintenance of paclitaxel-related chemotherapy-induced peripheral neuropathy. TLR4 and its immediate downstream signaling molecules-myeloid differentiation primary response gene 88 (MyD88) and toll/interleukin 1 receptor domain-containing adapter-inducing interferon-β (TRIF)-were found to be increased in the dorsal root ganglion (DRG) using Western blot by day 7 of paclitaxel treatment. The behavioral phenotype, the increase of both TLR4 and MyD88, was blocked by cotreatment with the TLR4 antagonist lipopolysaccharide-Rhodobacter sphaeroides during chemotherapy. A similar, but less robust, behavioral effect was observed using intrathecal treatment of MyD88 homodimerization inhibitory peptide. DRG levels of TLR4 and MyD88 reduced over the next 2 weeks, whereas these levels remained increased in spinal cord through day 21 following chemotherapy. Immunohistochemical analysis revealed TLR4 expression in both calcitonin gene-related peptide-positive and isolectin B4-positive small DRG neurons. MyD88 was only found in calcitonin gene-related peptide-positive neurons, and TRIF was found in both calcitonin gene-related peptide-positive and isolectin B4-positive small DRG neurons as well as in medium- and large-size DRG neurons. In the spinal cord, TLR4 was only found colocalized to astrocytes but not with either microglia or neurons. Intrathecal treatment with the TLR4 antagonist lipopolysaccharide-R. sphaeroides transiently reversed preestablished chemotherapy-induced peripheral neuropathy mechanical hypersensitivity. These results strongly implicate TLR4 signaling in the DRG and the spinal cord in the induction and maintenance of paclitaxel-related chemotherapy-induced peripheral neuropathy. PERSPECTIVE: The toll-like receptor TLR4 and MyD88 signaling pathway could be a new potential therapeutic target in paclitaxel-induced painful neuropathy.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DRG; LPS-RS; MyD88; Neuropathy; TLR4; TRIF; spinal cord

Mesh:

Substances:

Year:  2014        PMID: 24755282      PMCID: PMC4083500          DOI: 10.1016/j.jpain.2014.04.001

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  71 in total

1.  Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.

Authors:  Haijun Zhang; Seo-Yeon Yoon; Hongmei Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

2.  Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha.

Authors:  C J Woolf; A Allchorne; B Safieh-Garabedian; S Poole
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

3.  Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro.

Authors:  Yulin Chang; Xiaojing Huang; Zhaohui Liu; Guangwei Han; Lina Huang; Yuan-Chang Xiong; Zhengping Wang
Journal:  J Surg Res       Date:  2012-07-26       Impact factor: 2.192

4.  Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.

Authors:  Timothy Doyle; Zhoumou Chen; Carolina Muscoli; Leesa Bryant; Emanuela Esposito; Salvatore Cuzzocrea; Concetta Dagostino; Jan Ryerse; Smita Rausaria; Andrew Kamadulski; William L Neumann; Daniela Salvemini
Journal:  J Neurosci       Date:  2012-05-02       Impact factor: 6.167

5.  Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons.

Authors:  Silvia Balosso; Jaron Liu; Marco E Bianchi; Annamaria Vezzani
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

6.  Taxol and colchicine increase LPS-induced pro-IL-1 beta production, but do not increase IL-1 beta secretion. A role for microtubules in the regulation of IL-1 beta production.

Authors:  J M O'Brien; M D Wewers; S A Moore; J N Allen
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

7.  Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

Authors:  M Weintraub; M A Adde; D J Venzon; A T Shad; I D Horak; J E Neely; N L Seibel; J Gootenberg; C Arndt; M L Nieder; I T Magrath
Journal:  J Clin Oncol       Date:  1996-03       Impact factor: 44.544

8.  Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.

Authors:  Seo-Yeon Yoon; Caleb R Robinson; Haijun Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

9.  Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.

Authors:  Haijun Zhang; Jessica A Boyette-Davis; Alyssa K Kosturakis; Yan Li; Seo-Yeon Yoon; Edgar T Walters; Patrick M Dougherty
Journal:  J Pain       Date:  2013-05-31       Impact factor: 5.820

10.  The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain.

Authors:  Polina Feldman; Michael R Due; Matthew S Ripsch; Rajesh Khanna; Fletcher A White
Journal:  J Neuroinflammation       Date:  2012-07-23       Impact factor: 8.322

View more
  102 in total

Review 1.  Neuroimmune interactions in itch: Do chronic itch, chronic pain, and chronic cough share similar mechanisms?

Authors:  Ru-Rong Ji
Journal:  Pulm Pharmacol Ther       Date:  2015-09-06       Impact factor: 3.410

2.  Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice.

Authors:  Peng-Bo Jing; De-Li Cao; Si-Si Li; Meixuan Zhu; Xue-Qiang Bai; Xiao-Bo Wu; Yong-Jing Gao
Journal:  Neurosci Bull       Date:  2017-04-11       Impact factor: 5.203

Review 3.  Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain.

Authors:  Gang Chen; Yu-Qiu Zhang; Yawar J Qadri; Charles N Serhan; Ru-Rong Ji
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

4.  Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.

Authors:  Junliang Qian; Yanan Zhu; Liying Bai; Yan Gao; Mingjun Jiang; Fei Xing; Jian Zhang; Wenchao Zhao; Hanwen Gu; Yang Mi; Yuan-Xiang Tao; Ji-Tian Xu
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

5.  Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

Authors:  Lin Li; Jinxiu Li; Yan Zuo; Danny Dang; Jeffrey A Frost; Qing Yang
Journal:  J Pain       Date:  2018-11-22       Impact factor: 5.820

6.  Insights into the Contribution of Voltage-Gated Sodium Channel 1.7 to Paclitaxel-Induced Neuropathy.

Authors:  Laura Bernal
Journal:  J Neurosci       Date:  2018-07-04       Impact factor: 6.167

7.  MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.

Authors:  Yan Li; Hongmei Zhang; Alyssa K Kosturakis; Ryan M Cassidy; Haijun Zhang; Ross M Kennamer-Chapman; Abdul Basit Jawad; Cecilia M Colomand; Daniel S Harrison; Patrick M Dougherty
Journal:  Brain Behav Immun       Date:  2015-06-09       Impact factor: 7.217

8.  Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.

Authors:  Zachary A Curry; Jenny L Wilkerson; Deniz Bagdas; S Lauren Kyte; Nipa Patel; Giulia Donvito; Mohammed A Mustafa; Justin L Poklis; Micah J Niphakis; Ku-Lung Hsu; Benjamin F Cravatt; David A Gewirtz; M Imad Damaj; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2018-03-14       Impact factor: 4.030

Review 9.  How Do Sensory Neurons Sense Danger Signals?

Authors:  Christopher R Donnelly; Ouyang Chen; Ru-Rong Ji
Journal:  Trends Neurosci       Date:  2020-08-21       Impact factor: 13.837

10.  Adaptive mechanisms driving maladaptive pain: how chronic ongoing activity in primary nociceptors can enhance evolutionary fitness after severe injury.

Authors:  Edgar T Walters
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-09-23       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.